Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5Other hematologic neoplasm 3Breast 3Lymphoid 2Thoracic 1

Conditions

Pathologic Processes 1Lymphatic Metastasis 1Lung Neoplasms 1

Interventions

Carboplatin 202pembrolizumab 166Pemetrexed 140Cisplatin 124Paclitaxel 77durvalumab 74osimertinib 69Nivolumab 68Docetaxel 66Specimen Handling 64atezolizumab 57Magnetic Resonance Spectroscopy 53Etoposide 47Gemcitabine 46Radiotherapy 43Radiosurgery 40130-nm albumin-bound paclitaxel 34Drug Therapy 32Bevacizumab 29Ipilimumab 28Cetuximab 27cemiplimab 25Taxes 24tislelizumab 21Immunoglobulin G 21Platinum 20Biopsy 20amivantamab 19Radiation 19Disulfides 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Control Groups × Thoracic × 90 days × Clear all
NCT06252129 2026-03-05

Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens

Brigham and Women's Hospital

Phase NA Recruiting
160 enrolled
Thoracic

Lung Neoplasms, Lymphatic Metastasis, Pathologic Processes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡